MedPath

Comparison of Apnea Tolerance in Two Positions of Patients With BMI 30-40

Not Applicable
Completed
Conditions
General Surgery
Interventions
Other: 25° head-up position
Other: 55° head-up position
Registration Number
NCT03056820
Lead Sponsor
University of Kansas Medical Center
Brief Summary

The purpose of this study is to compare the effect of the 25° head-up position versus the 55° head-up position on tolerable apnea time (TAT) after induction of general anesthesia in patients with a body mass index (BMI) of 30-40.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
74
Inclusion Criteria
  • American Society of Anesthesiologists (ASA) physical status I-III
  • Body Mass Index (BMI) of 30-40
  • Scheduled for an elective surgery that requires tracheal intubation
Exclusion Criteria
  • Patients with abnormalities of the upper airway that require awake tracheal intubation
  • Asthma
  • Chronic obstructive pulmonary disease
  • Congestive heart failure
  • Pregnant patients

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
A - 25° head-up position25° head-up positionParticipants will be positioned at 25° angle for procedure.
B - 55° head-up position55° head-up positionParticipants will be positioned at 55° angle for procedure.
Primary Outcome Measures
NameTimeMethod
Tolerable Apnea Time (TAT)Time between start of induction of general anesthesia (SpO2 100%) to decline of SpO2 94%, up to eight minutes

Measure of the TAT between groups to determine if the TAT is a function of the participant's position.

Secondary Outcome Measures
NameTimeMethod
Length of time to intubation (TTI)Time between start of the tracheal intubation procedure to completion of tracheal intubation, up to 2 minutes
Peripheral arterial hemoglobin oxygen saturation (SpO2) troughTime until SpO2 decreased to 92%, up to 8 minutes

Measure of the rebound SpO2. It is the lowest SpO2 reading reached subsequent to start of mechanical ventilation at the SpO2 value of 94% and it represents final completion of SpO2 decline.

Trial Locations

Locations (1)

University of Kansas Medical Center

🇺🇸

Kansas City, Kansas, United States

© Copyright 2025. All Rights Reserved by MedPath